Immunologic Function in the Elderly After Injury

This study has been completed.
Sponsor:
Information provided by:
Summa Health System
ClinicalTrials.gov Identifier:
NCT00447135
First received: August 7, 2006
Last updated: January 28, 2008
Last verified: January 2008
  Purpose

The purpose of this research is to learn more about the function of the body's ability to fight infection when the immune response is activated when injury occurs, in the elderly population.


Condition
Over the Age of 65
Admitted to the Trauma Service

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Immunologic Function in the Elderly After Injury: the Polymorphonuclear Leukocyte (PMN) and Innate Immunity

Resource links provided by NLM:


Further study details as provided by Summa Health System:

Enrollment: 55
Study Start Date: March 2005
Study Completion Date: December 2005
Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   66 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Elderly after injury

Criteria

Inclusion Criteria:

  • Greater than 65
  • Admitted to the trauma service

Exclusion Criteria:

  • Inability to draw sufficient blood
  • Immunocompromised
  • Currently receiving systemic corticosteroids
  • Participation in other studies
  • In the opinion of the investigator will not be able to complete protocol
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00447135

Locations
United States, Ohio
Summa Health System
Akron, Ohio, United States, 44304
Sponsors and Collaborators
Summa Health System
Investigators
Principal Investigator: William Fallon, MD Summa Health System
  More Information

No publications provided

Responsible Party: Dr. William Fallon, Summa Health System
ClinicalTrials.gov Identifier: NCT00447135     History of Changes
Other Study ID Numbers: 04104
Study First Received: August 7, 2006
Last Updated: January 28, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by Summa Health System:
Elderly
Trauma
Polymorphonuclear Leukocyte
Immunity

ClinicalTrials.gov processed this record on October 01, 2014